Photobiomodulation promotes neural regeneration when compared to simvastatin treatment in a sciatic nerve crush model

Lasers Med Sci. 2021 Oct;36(8):1591-1597. doi: 10.1007/s10103-020-03176-y. Epub 2020 Nov 18.

Abstract

To determine whether the effects of photobiomodulation (PBM) were associated with the use of Simvastatin in the functional recovery from sciatic nerve in mice submitted to crush injury. Fifty Swiss mice (approximately 3 months old; average weight 40 g) were randomly divided into six groups: naive, sham, control, PBM (660 nm, 10 J/cm2; 30 mW; 0.6 J per day for 28 days; 0.06 cm2; 16.8 J total and 20 s), Simvastatin (20 mg/kg), and PBM/Simv (association of the two protocols). The sciatic functional index (SFI), thermal heat hyperalgesia, mechanical hyperalgesia, and thermographic evaluation were used as analyses. The evaluations were performed preoperatively and 7, 14, 21, and 28 days after the initial injury analyzed by two-way analysis of variance (ANOVA) for mixed models followed by the Bonferroni post-test. All groups except sham and naive presented an SFI compatible with severe peripheral nerve injury on the 7th day of evaluation. The PBM group presented better results in the SFI analysis (p < 0.001) on the 21st postoperative day compared to the control group. This benefit was maintained when compared to the Simvastatin (p < 0.001) and PBM/Simv groups (p < 0.01). The results of the thermal and mechanical hyperalgesia and thermography analyses were not significant (p > 0.05). The obtained results showed that PBM alone was more effective compared to Simvastatin alone or PBM combined with Simvastatin for sciatic nerve injury in mice.

Keywords: Crush injury; Electrophysical agents; Low-level laser therapy; Peripheral nerve; Regeneration; Simvastatin.

MeSH terms

  • Animals
  • Mice
  • Nerve Crush
  • Nerve Regeneration
  • Peripheral Nerve Injuries* / drug therapy
  • Sciatic Nerve
  • Sciatic Neuropathy* / drug therapy
  • Simvastatin / therapeutic use

Substances

  • Simvastatin